GET CARE ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.2% 15.1% 9.5% 12.3% 10.6%  
Credit score (0-100)  44 13 24 18 22  
Credit rating  BBB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  11,536 767 -5.5 -12.0 -5.7  
EBITDA  1,507 -484 -6.2 -12.0 -5.7  
EBIT  1,381 -524 -6.2 -12.0 -5.7  
Pre-tax profit (PTP)  1,345.8 -542.9 -6.2 -12.0 -5.7  
Net earnings  1,042.1 -435.5 -2.6 -9.3 -4.4  
Pre-tax profit without non-rec. items  1,346 -543 -6.2 -12.0 -5.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  154 0.0 0.0 0.0 0.0  
Shareholders equity total  541 105 103 93.2 88.8  
Interest-bearing liabilities  218 533 420 416 416  
Balance sheet total (assets)  2,780 1,329 1,244 516 511  

Net Debt  81.1 512 420 416 416  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  11,536 767 -5.5 -12.0 -5.7  
Gross profit growth  5.5% -93.4% 0.0% -118.8% 52.3%  
Employees  26 1 1 1 1  
Employee growth %  13.0% -96.2% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,780 1,329 1,244 516 511  
Balance sheet change%  -33.8% -52.2% -6.4% -58.5% -0.9%  
Added value  1,507.1 -483.5 -6.2 -12.0 -5.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -205 -194 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  12.0% -68.3% 113.1% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  39.6% -25.5% -0.5% -1.4% -1.1%  
ROI %  99.9% -75.0% -1.1% -2.3% -1.1%  
ROE %  82.1% -134.9% -2.5% -9.5% -4.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  19.4% 7.9% 8.2% 18.1% 17.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  5.4% -105.9% -6,786.8% -3,479.6% -7,292.2%  
Gearing %  40.2% 506.9% 409.1% 446.1% 468.1%  
Net interest  0 0 0 0 0  
Financing costs %  31.9% 5.2% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.2 1.1 1.1 1.2 1.2  
Current Ratio  1.2 1.1 1.1 1.2 1.2  
Cash and cash equivalent  136.5 20.9 0.0 0.0 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  352.0 105.2 102.6 93.2 88.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  58 -484 -6 -12 -6  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  58 -484 -6 -12 -6  
EBIT / employee  53 -524 -6 -12 -6  
Net earnings / employee  40 -436 -3 -9 -4